Merck and Shering-Plough had better get their houses in order. Congress is on the case:
Apparently, representatives of the US populus, which pays for a substantial portion of the Zetia sold, are not pleased by the delays in release of the data from the ENHANCE trial. The chicanery is going to be harder to sustain.
I certainly hope for everyone's sake (especially patients') that there is no foul play afoot with this trial or ezetimibe - Merck can hardly withstand another round of Vioxx-type suits, can it? Or can it. Merck's stock price (MRK: http://finance.yahoo.com/q/bc?s=MRK&t=5y&l=on&z=m&q=l&c=) is at the same level as it was in Jan, 2004. Some high price to pay for obfuscating the truth, concealing evidence of harm, bilking insurers and the American public and government for billions of $$$ for a prescription painkiller when equivalent non-branded products were available, and causing thousands of heart attacks in the process....
The consequences should be harsher the second time around.....
Type rest of the post here
This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.
Wednesday, December 12, 2007
ENHANCE trial faces congressional scrutiny
Subscribe to: Post Comments (Atom)
Would you mind either posting a copy of the trial or emailing it to me? I'm curious how the patient population and mode of evaluation in Enhance compares to the Reversal and Asteroid trials.ReplyDelete
Sir or Madam -ReplyDelete
The trial results have not yet been released in full. Data are said to be presented at the ACC meeting in Chicago in March. Hope to see you there!
Thank you for replying. I look forward to possibly meeting you at ACC in March.ReplyDelete
I wouldn't mind "possibly meeting" you either, Dr. Aberegg.ReplyDelete
With highest regards,
You don't look like you discriminate, I too hope to see you at the ACC in March.ReplyDelete